Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.
Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.
LoginUpgrade to see which companies are likely to bid on this tender, based on historical procurement data.
LoginAI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.
Login3 documents available with AI summaries
This OCDS record provides official data on a tender award or contract publication by The Royal Marsden NHS Foundation Trust for the provision of radiopharmaceuticals.
This document is an OCDS Release Package providing structured data about a procurement for radiopharmaceuticals, detailing the contracting authority, involved parties, and award/contract information.
This document is a contract award notice from The Royal Marsden NHS Foundation Trust, announcing the direct award of a £2.42 million contract for radiopharmaceuticals to Xiel Ltd, with an estimated contract period from March 2026 to March 2028.
Sign up to view document summaries and analysis
Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.
LoginHello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required